Acquisition FAQs for Celgene Shareholders

Who do I contact to get information about receiving the merger consideration?

What happened with my existing Celgene shares?

What exactly is a CVR?

What is the ticker for the CVR?

Can I sell my CVR?

Why is the CVR trading for a price different than the potential $9.00 payout?

What are the tax consequences to me of receiving the merger consideration (i.e., 1 share of Bristol Myers Squibb stock, $50 cash and 1 CVR for each of my vested Celgene shares)?

What are the tax consequences of receiving the CVR milestone payment?

Is the exchange of my Celgene common shares for shares of Bristol Myers Squibb common stock and cash mandatory?

How do I exchange my Celgene shares?

What if I can’t locate all of my Celgene share certificates?

What if I have certificated Celgene shares in more than one account?

What happened to my existing Abraxis/Abraxane CVR?

Please remind me what triggers a payout under the Abraxis CVR (CELGRT, formerly CELGZ)?

Who is the exchange agent?

 

FAQs for BMY Shareholders

Frequently asked questions about Bristol Myers Squibb shares.

Learn More